Bacterial urinary tract infections in diabetes.

Complicated urinary tract infection in adults. Can J Infect Dis Med Microbiol (2005) 1.52

Emphysematous cystitis: An atypical multi-organism presentation. Can Urol Assoc J (2014) 1.41

Clinico-microbiological profile of urinary tract infection in south India. Indian J Nephrol (2011) 1.28

Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates. J Gen Intern Med (1999) 1.28

Diabetic complications and dysregulated innate immunity. Front Biosci (2008) 1.28

Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management. Diabetes Metab Syndr Obes (2015) 1.23

Imaging of acute pyelonephritis in the adult. Eur Radiol (2006) 1.08

A Case of Complicated Urinary Tract Infection: Klebsiella pneumoniae Emphysematous Cystitis Presenting as Abdominal Pain in the Emergency Department. West J Emerg Med (2008) 1.03

Streptozocin-induced diabetic mouse model of urinary tract infection. Infect Immun (2008) 1.02

Acute focal bacterial nephritis in 25 children. Pediatr Nephrol (2007) 0.90

Prevalence of Urinary Tract Infection and Antimicrobial Susceptibility among Diabetic Patients with Controlled and Uncontrolled Glycemia in Kuwait. J Diabetes Res (2015) 0.89

Prevalence of urinary tract infection and risk factors among Saudi patients with diabetes. World J Urol (2012) 0.87

Adiponectin-induced secretion of interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1, CCL2) and interleukin-8 (IL-8, CXCL8) is impaired in monocytes from patients with type I diabetes. Cardiovasc Diabetol (2006) 0.87

Microbiological outcomes in women with diabetes and untreated asymptomatic bacteriuria. World J Urol (2005) 0.86

Role of the cAMP-dependent carbon catabolite repression in capsular polysaccharide biosynthesis in Klebsiella pneumoniae. PLoS One (2013) 0.85

Risk Factors for Development of Acute Kidney Injury in Patients with Urinary Tract Infection. PLoS One (2015) 0.84

Lipopolysaccharide regulated protein expression is only partly impaired in monocytes from patients with type I diabetes. Cardiovasc Diabetol (2006) 0.83

Association between mannose-binding lectin deficiency and septic shock following acute pyelonephritis due to Escherichia coli. Clin Vaccine Immunol (2007) 0.82

Prevalence of uropathogens in diabetic patients and their corresponding resistance pattern: results of a survey conducted at diagnostic centers in dhaka, bangladesh. Oman Med J (2010) 0.80

Emphysematous cystitis in a patient with type-2 diabetes mellitus. Indian J Endocrinol Metab (2011) 0.79

Urinary tract infections and antimicrobial sensitivity among diabetic patients at Khartoum, Sudan. Ann Clin Microbiol Antimicrob (2015) 0.77

Diabetes Mellitus has no Significant Influence on the Prevalence of Antenatal Asymptomatic Bacteriuria. J Clin Diagn Res (2016) 0.75

CRP-Cyclic AMP Regulates the Expression of Type 3 Fimbriae via Cyclic di-GMP in Klebsiella pneumoniae. PLoS One (2016) 0.75

Emphysematous Pyelonephritis Caused by Citrobacter freundii in a Patient with Type 2 Diabetes and Neurogenic Bladder. Infect Chemother (2013) 0.75

Effect of diabetes on mortality and length of hospital stay in patients with renal or perinephric abscess. Clinics (Sao Paulo) (2013) 0.75

The association between diabetes mellitus and incident infections: a systematic review and meta-analysis of observational studies. BMJ Open Diabetes Res Care (2017) 0.75

In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother (1982) 5.54

Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 4.20

Activity of minocycline against Acinetobacter calcoaceticus var. anitratus (syn. Herellea vaginicola) and Serratia marcescens. Antimicrob Agents Chemother (1975) 2.92

Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis. Antimicrob Agents Chemother (1996) 2.52

The diagnosis of invasive aspergillosis by an enzyme-linked immunosorbent assay for circulating antigen. J Infect Dis (1985) 2.44

Treatment of experimental invasive aspergillosis with novel amphotericin B/cholesterol-sulfate complexes. J Infect Dis (1989) 2.08

Antibiotic synergy in experimental infection with Pseudomonas. II. The effect of carbenicillin, cephalothin, or cephanone combined with tobramycin or gentamicin. J Infect Dis (1974) 2.00

Synergy of carbenicillin and gentamicin in experimental infection with Pseudomonas. J Infect Dis (1971) 1.77

In vitro antibacterial activity of a new 1-oxa cephalosporin compound. Yale J Biol Med (1980) 1.70

Coagulase-negative staphylococcus. Ann N Y Acad Sci (1970) 1.68

Current concepts in cryptococcosis. Eur J Clin Microbiol Infect Dis (1989) 1.65

Effect of immunosuppression and amphotericin B on Aspergillus antigenemia in an experimental model. J Infect Dis (1988) 1.65

Gram-negative bacillary meningitis. Am J Med (1975) 1.64

Development of meningitis during cephalothin therapy. Ann Intern Med (1973) 1.62

The epidemiology of pseudallescheriasis complicating transplantation: nosocomial and community-acquired infection. Mycoses (1990) 1.53

Optimal therapy for enterococcal endocarditis. Am J Med (1984) 1.46

Detection, significance, and therapy of bacteriuria in pregnancy. Update in the managed health care era. Infect Dis Clin North Am (1997) 1.43

Association between serum inhibitory and bactericidal concentrations and therapeutic outcome in bacterial endocarditis. Am J Med (1982) 1.42

Antiendotoxin monoclonal antibodies for gram-negative sepsis: guidelines from the IDSA. Clin Infect Dis (1992) 1.41

Efficacy of SCH 39304 in treatment of experimental invasive aspergillosis. Antimicrob Agents Chemother (1991) 1.39

Combination therapy in experimental invasive aspergillosis. J Infect Dis (1993) 1.36

Bacteriuria in pregnancy. Infect Dis Clin North Am (1987) 1.32

The role of fluconazole in the early treatment and prophylaxis of experimental invasive aspergillosis. J Infect Dis (1991) 1.29

An experimental model of amphotericin B nephrotoxicity with renal tubular acidosis. J Lab Clin Med (1971) 1.27

The effect and critical duration of increased tissue pressure on susceptibility to bacterial infection. Br J Exp Pathol (1965) 1.25

Antibiotic sensitivities of nonpigmented serratia marcescens to gentamicin and carbenicillin. J Infect Dis (1969) 1.24

Carbenicillin: clinical and laboratory studies. J Infect Dis (1970) 1.23

Activity of LY146032 in vitro and in experimental enterococcal pyelonephritis. Antimicrob Agents Chemother (1987) 1.19

A paradigm for human chronic osteomyelitis. J Bone Joint Surg Am (1973) 1.18

Acceleration of the inflammatory response of the renal medulla by water diuresis. J Clin Invest (1966) 1.18

Cephalexin: clinical and laboratory studies. Yale J Biol Med (1971) 1.18

A solid-phase radioimmunoassay for the measurement of antibody to Aspergillus in invasive aspergillosis. J Infect Dis (1979) 1.16

Cryptococcal infection of the central nervous system. Med Clin North Am (1985) 1.14

Laboratory and clinical studies of a new antibiotic, cephaloridine, in the treatment of gram-positive infections. Yale J Biol Med (1966) 1.14

Accuracy of grey-scale ultrasound diagnosis of abdominal and pelvic abscesses in 220 patients. Lancet (1978) 1.13

Bacteriuria during indwelling catheter drainage. Effect of constant bladder rinse. JAMA (1966) 1.11

Effect of water diuresis on chronic pyelonephritis. J Lab Clin Med (1968) 1.09

Aspergillus antigen detection in the diagnosis of invasive aspergillosis. J Infect Dis (1995) 1.09

Laboratory and clinical studies of a new antibiotic, cephaloglycin in the treatment of urinary tract infections. Yale J Biol Med (1968) 1.08

A new method for measuring antibody using radiolabeled protein A1 in a solid-phase radioimmunoassay. J Immunol Methods (1979) 1.07

Role of the infectious disease specialist in containing costs of antibiotics in the hospital. Rev Infect Dis (1986) 1.07

The role of liposomal amphotericin B in the treatment of systemic fungal infections. Eur J Cancer Clin Oncol (1989) 1.07

Usefulness of serial antibody determinations in diagnosis of candidiasis as measured by discontinuous counterimmunoelectrophoresis using HS antigen. J Clin Microbiol (1978) 1.07

In vitro susceptibility of selected bacteria to cefaclor. Yale J Biol Med (1978) 1.06

Saperconazole therapy in a rabbit model of invasive aspergillosis. Antimicrob Agents Chemother (1992) 1.03

Pharmacokinetics of cephalosporins in patients with normal or reduced renal function. J Infect Dis (1978) 1.01

Efficacies of two new antifungal agents, the triazole ravuconazole and the echinocandin LY-303366, in an experimental model of invasive aspergillosis. Antimicrob Agents Chemother (2000) 0.99

Renal and perirenal abscesses. Infect Dis Clin North Am (1997) 0.98

Efficacy of fluconazole in experimental invasive aspergillosis. Rev Infect Dis (1990) 0.97

Enterococcal meningitis: combined vancomycin and rifampin therapy. Am J Med (1980) 0.96

Comparative efficacy of ciprofloxacin, azlocillin, and tobramycin alone and in combination in experimental Pseudomonas sepsis. J Infect Dis (1987) 0.95

Urinary tract antiseptics. Med Clin North Am (1982) 0.95

Whole blood phagocytic and bactericidal activity for Staphylococcus aureus. J Lab Clin Med (1972) 0.92

Synergism of oxacillin and gentamicin against enterococci. Antimicrob Agents Chemother (1975) 0.91

Pseudomonas bacteremia: can antibiotic therapy improve survival? J Lab Clin Med (1979) 0.91

Cefoperazone versus combination antibiotic therapy of hospital-acquired pneumonia. Am J Med (1988) 0.91

Imaging experimental infective endocarditis with indium-111-labeled blood cellular components. Circulation (1979) 0.91

Cefoperazone versus ceftriaxone monotherapy of nosocomial pneumonia. Diagn Microbiol Infect Dis (1992) 0.91

Effect of peritoneal dialysis on serum levels of tobramycin and clindamycin. Antimicrob Agents Chemother (1975) 0.90

Antibody to Tamm-Horsfall protein in patients with urinary tract obstruction and vesicoureteral reflux. J Infect Dis (1978) 0.90

Tubulointerstitial nephritis and immunologic responses to Tamm-Horsfall protein in rabbits challenged with homologous urine or Tamm-Horsfall protein. J Immunol (1982) 0.90

Oral ciprofloxacin in resistant urinary tract infections. Am J Med (1987) 0.89

Hospital epidemiologic surveillance for invasive aspergillosis: patient demographics and the utility of antigen detection. Infect Control Hosp Epidemiol (1997) 0.88

Four-valve polymicrobial endocarditis caused by Pseudomonas aeruginosa and Serratia marcescens. Am J Med (1982) 0.88

Renal and perirenal abscesses. Infect Dis Clin North Am (1987) 0.87

Prophylactic antibiotics in gynecologic surgery. Obstet Gynecol (1979) 0.87

Bacterial urinary tract infections in diabetes. Infect Dis Clin North Am (1995) 0.86

Arteriography and antibiotic therapy of a renal carbuncle. J Urol (1972) 0.85

Streptococcal endocarditis (nonenterococcal, non-group A): single vs combination therapy. JAMA (1979) 0.85

Contaminated stethoscopes: a potential source of nosocomial infections. Yale J Biol Med (1972) 0.85

Immunopathogenesis of chronic pyelonephritis. Am J Med (1983) 0.84

Comparison of continuous and discontinuous counterimmunoelectrophoresis with immunodiffusion in identification of candida antibody using HS antigen. J Clin Microbiol (1978) 0.84

Transient bacteremia due to suction abortion: implications for SBE antibiotic prophylaxis. Yale J Biol Med (1978) 0.83

Endometrial and vaginal cuff bacteria recovered at elective hysterectomy during a trial of antibiotic prophylaxis. Am J Obstet Gynecol (1978) 0.83

Incidence, timing and site of infections among pancreas transplant recipients. J Hosp Infect (2004) 0.82

The role of Tamm-Horsfall protein in the pathogenesis of reflux nephropathy and chronic pyelonephritis. Yale J Biol Med (1985) 0.82

Chronic staphylococcal osteomyelitis: an experimental model. Yale J Biol Med (1974) 0.82

Advances in the treatment of urinary infections. J Antimicrob Chemother (1982) 0.82

Fungal infections of the CNS. Neurol Clin (1986) 0.82

Bacteriuria during indwelling catheter drainage. II. Effect of a closed sterile drainage system. JAMA (1970) 0.81

Tubulointerstitial nephritis in rabbits challenged with homologous Tamm-Horsfall protein: the role of endotoxin. Clin Exp Immunol (1983) 0.81

Cefoperazone versus ceftazidime monotherapy of nosocomial pneumonia. Am J Med (1988) 0.81

Candida peritonitis complicating peritoneal dialysis: successful treatment with low dose amphotericin B therapy. Clin Nephrol (1976) 0.81

Tamm-Horsfall protein antibody in patients with end-stage kidney disease. Yale J Biol Med (1980) 0.80

Tetracycline-resistant pneumococcal infection. Incidence, clinical presentation, and laboratory evaluation. Arch Intern Med (1969) 0.80

Water, acidosis, and experimental pyelonephritis. J Clin Invest (1970) 0.80

Neutropenia during high dose intravenous oxacillin therapy. Yale J Biol Med (1976) 0.80

Treatment of opportunistic infections complicating surgery. Mod Treat (1966) 0.80

Antibiotic treatment of renal carbuncle. Ann Intern Med (1977) 0.80

Value of the serum bactericidal test in management of patients with bacterial endocarditis. Eur J Clin Microbiol (1986) 0.80

Pharmacokinetics of cefamandole in patients undergoing hemodialysis and peritoneal dialysis. Antimicrob Agents Chemother (1976) 0.78

Interaction of Tamm-horsfall protein with bacterial extracts. Kidney Int (1987) 0.78

Synergy of vancomycin with penicillins and cephalosporins against pseudomonas, klebsiella, and serratia. Yale J Biol Med (1977) 0.78

Colchicine: anti-inflammatory effect of low doses in a sensitive bacterial system. J Lab Clin Med (1968) 0.78

Staphylococci and combination therapy. Arch Intern Med (1979) 0.78

Infectious complications associated with renal transplantation: an analysis of risk factors. Yale J Biol Med (1979) 0.78

Aspergillus vertebral osteomyelitis after simultaneous kidney-pancreas transplantation. Transpl Infect Dis (2003) 0.78

Technetium-99m stannous pyrophosphate imaging of experimental infective endocarditis. Circulation (1978) 0.77

Efficacy of ciprofloxacin in animal models of infection. Am J Med (1987) 0.77

In-vitro activity of trovafloxacin against sensitive and resistant aerobic bacteria using the standard microdilution broth method and Etest. J Antimicrob Chemother (1997) 0.76